MacroGenics
MGNX
#9452
Rank
โ‚ฌ0.11 B
Marketcap
1,79ย โ‚ฌ
Share price
-1.01%
Change (1 day)
45.14%
Change (1 year)

EPS for MacroGenics (MGNX)

EPS in 2026 (TTM): -0,48ย โ‚ฌ

According to MacroGenics's latest financial reports the company's current EPS (TTM) is -0,52ย โ‚ฌ. In 2025 the company made an earnings per share (EPS) of -1,08ย โ‚ฌ a decrease over its 2024 EPS that were of -0,98ย โ‚ฌ.

EPS history for MacroGenics from 2011 to 2026

Annual EPS

Year EPS Change
2026 (TTM)-0,48ย โ‚ฌ-55.1%
2025-1,08ย โ‚ฌ10.28%
2024-0,98ย โ‚ฌ613.33%
2023-0,14ย โ‚ฌ-92.31%
2022-1,78ย โ‚ฌ-42.14%
2021-3,07ย โ‚ฌ36.44%
2020-2,25ย โ‚ฌ-21.84%
2019-2,88ย โ‚ฌ-24.58%
2018-3,82ย โ‚ฌ675.93%
2017-0,49ย โ‚ฌ-68.05%
2016-1,54ย โ‚ฌ168.25%
2015-0,57ย โ‚ฌ-55%
2014-1,28ย โ‚ฌ3400%
2013-0,03646ย โ‚ฌ-108.68%
20120,42ย โ‚ฌ24.49%
20110,34ย โ‚ฌ

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Pfizer
PFE
0,65ย โ‚ฌ-224.56%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
28,16ย โ‚ฌ-5,519.44%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
15,84ย โ‚ฌ-3,149.12%๐Ÿ‡บ๐Ÿ‡ธ USA
Gilead Sciences
GILD
-2,83ย โ‚ฌ 443.86%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
0,91ย โ‚ฌ-274.22%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
4,12ย โ‚ฌ-892.98%๐Ÿ‡บ๐Ÿ‡ธ USA
Xencor
XNCR
-1,43ย โ‚ฌ 175.44%๐Ÿ‡บ๐Ÿ‡ธ USA